From March 1, 2023 to July 27, 2023, the company has repurchased 266,800 shares, representing 0.29% for CAD 0.24 million. With this, the company has completed the repurchase of 296,800 shares, representing 0.33% for CAD 0.26 million under the buyback announced on November 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 CAD | 0.00% |
|
-5.56% | -18.07% |
1st Jan change | Capi. | |
---|---|---|
-18.07% | 4.48Cr | |
+20.58% | 24Cr | |
-1.03% | 20Cr | |
+300.00% | 12Cr | |
+39.09% | 13Cr | |
-35.71% | 12Cr | |
+73.40% | 9.87Cr | |
-60.43% | 8.36Cr | |
0.00% | 8.71Cr |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.